Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia
about
Paediatric acute myeloid leukaemia with the t(7;12)(q36;p13) rearrangement: a review of the biological and clinical management aspectsPediatric AML: From Biology to Clinical Managementt(6;9)(p22;q34)/DEK-NUP214-rearranged pediatric myeloid leukemia: an international study of 62 patients.Copy-neutral loss of heterozygosity is prevalent and a late event in the pathogenesis of FLT3/ITD AMLClassification of pediatric acute myeloid leukemia based on miRNA expression profiles.Understanding disease mechanisms with models of signaling pathway activities.Visualising the cross-level relationships between pathological and physiological processes and gene expression: analyses of haematological diseasesEngagement of SIRPα inhibits growth and induces programmed cell death in acute myeloid leukemia cells.Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group.Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international studyGene expression profiles associated with pediatric relapsed AML.Subtype prediction in pediatric acute myeloid leukemia: classification using differential network rank conservation revisitedAcute myeloid leukemia and transcription factors: role of erythroid Krüppel-like factor (EKLF).Gene expression profiling in MDS and AML: potential and future avenues.The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia.Genome-scale technology driven advances to research into normal and malignant haematopoiesis.Hox gene dysregulation in acute myeloid leukemia.Meta-analytic framework for sparse K-means to identify disease subtypes in multiple transcriptomic studiesTransformation of human CD34+ hematopoietic progenitor cells with DEK-NUP214 induces AML in an immunocompromised mouse model.Integrative Sparse K-Means With Overlapping Group Lasso in Genomic Applications for Disease Subtype Discovery.Instruction of haematopoietic lineage choices, evolution of transcriptional landscapes and cancer stem cell hierarchies derived from an AML1-ETO mouse model.LIN28B is over-expressed in specific subtypes of pediatric leukemia and regulates lncRNA H19.MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.Network-based sub-network signatures unveil the potential for acute myeloid leukemia therapy.Cooperation of MLL/AF10(OM-LZ) with PTPN11 activating mutation induced monocytic leukemia with a shorter latency in a mouse bone marrow transplantation model.Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the aieop AML-2002/01 study.Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia.Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrationsCBLmutations do not frequently occur in paediatric acute myeloid leukaemia
P2860
Q26775693-EE35B0D0-063D-432F-91B8-54807BE1DE02Q26799773-48F97C8B-3DB5-4A71-BF5F-DB4E40F7D42BQ33558727-4058958D-9FD8-43D8-A109-CF2A784640AEQ33702150-E076E1C0-B696-4672-959D-D439F1E56ABFQ33779361-00012B9F-F92E-4660-BFEF-B621B62915A8Q34422921-92C5674B-8B2F-4853-9554-12F7D760C6E0Q34542542-6F611AD8-0628-41B3-8D25-732E707B5C8DQ34548156-B7845801-9E94-47F7-8E6D-0F888EF883F3Q35040531-38B1D515-4C36-4335-B756-8851F213F50EQ35127974-8A7EA331-CDE4-439B-B475-1696DE4ADB94Q35302035-A892511C-E989-440A-9F26-F867875B9579Q35785820-54120FCD-D314-4FC7-945D-2B530F018C6FQ36125618-01599916-8317-4B75-8264-B0D9A412EA75Q37858877-72762FCC-6D26-410A-BCB1-226895041E16Q37874929-78BE7420-6922-49E7-B400-5128A6A1894EQ38166364-B432A58F-3F72-48FF-8328-4F8C6BCB5225Q38190116-650CB753-C552-4592-A816-42696383A190Q39665271-56D88D71-A050-41D3-8D7F-4A467C4DDA9EQ40513891-73FD30A8-A8AD-4723-BADC-A9EB02FF0F68Q41687889-D2E5DA01-DB7F-4311-8909-60A37DFD0B3DQ41916176-5DC2790A-3BB8-4F1B-BBC2-930633AEA8D3Q42397452-54346836-9A2C-4D1B-A99F-A8603204A2D9Q50159472-54FBC78E-0C0F-4F78-8687-F18241FF714BQ51025557-C7278F1F-A51A-40B4-B649-AEBAEA62F8F8Q51320671-231D22FC-A272-424B-92C7-A70CF3616CABQ54310310-576D545C-1D92-49F9-9D67-FAD481FAD28CQ54569630-4E11039C-D5CA-414C-AC6F-C8A84C5D7504Q58481795-1D70865D-74A8-4A7E-9825-C4F590BC41E6Q58492894-BD2C3354-253B-4AFD-965A-2B5A6AF5CD77
P2860
Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Evaluation of gene expression ...... diatric acute myeloid leukemia
@ast
Evaluation of gene expression ...... diatric acute myeloid leukemia
@en
Evaluation of gene expression ...... diatric acute myeloid leukemia
@nl
type
label
Evaluation of gene expression ...... diatric acute myeloid leukemia
@ast
Evaluation of gene expression ...... diatric acute myeloid leukemia
@en
Evaluation of gene expression ...... diatric acute myeloid leukemia
@nl
prefLabel
Evaluation of gene expression ...... diatric acute myeloid leukemia
@ast
Evaluation of gene expression ...... diatric acute myeloid leukemia
@en
Evaluation of gene expression ...... diatric acute myeloid leukemia
@nl
P2093
P2860
P1433
P1476
Evaluation of gene expression ...... diatric acute myeloid leukemia
@en
P2093
Andre Baruchel
Brian V Balgobind
C Michel Zwaan
Claus Meyer
Dirk Reinhardt
Elisabeth R van Wering
Evelien S J M de Bont
Gertjan J L Kaspers
H Berna Beverloo
Iris H I M Hollink
P2860
P304
P356
10.3324/HAEMATOL.2010.029660
P577
2010-10-22T00:00:00Z